- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Type 2 Diabetes Mellitus
Total 105381 results
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
AstraZenecaOno Pharmaceutical Co. LtdCompletedType 2 Diabetes MellitusJapan
-
University of LeicesterUniversity Hospitals, Leicester; Loughborough University; Baker Heart and Diabetes...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
Eli Lilly and CompanyTerminatedType 2 Diabetes MellitusUnited States
-
Astellas Pharma IncCompletedType 2 Diabetes MellitusJapan
-
TakedaCompletedType 2 Diabetes MellitusChina
-
Melior PharmaceuticalsBukwang Pharmaceutical, Co., Ltd.UnknownType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
Xijing HospitalXi'an Central Hospital; First Affiliated Hospital Xi'an Jiaotong University; Shaanxi... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
Nova Scotia Health AuthorityWithdrawnType2 Diabetes Mellitus
-
University of GuelphOntario Ministry of Agriculture, Food and Rural Affairs; Maple Leaf Foods,...CompletedType 2 Diabetes MellitusCanada
-
University of GuelphAgriculture and Agri-Food Canada; Natural Sciences and Engineering Research... and other collaboratorsCompletedType 2 Diabetes MellitusCanada
-
Bispebjerg HospitalUniversity of Copenhagen; University of AarhusCompletedType 2 Diabetes MellitusDenmark
-
University Hospital, Strasbourg, FranceNovartisCompleted
-
University of Alabama at BirminghamTerminatedType 2 Diabetes MellitusUnited States
-
Abbott Diabetes CareCompletedType 2 Diabetes MellitusFrance, United Kingdom, Germany
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
NovartisCompletedType 2 Diabetes MellitusTaiwan, Philippines, Italy, Germany, Romania, Hungary, Australia, Korea, Republic of, Mexico
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
vTv TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusGermany
-
Lawson Health Research InstituteJanssen Inc.CompletedType 2 Diabetes MellitusCanada
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
UMC UtrechtCompletedShared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.Type 2 Diabetes MellitusNetherlands
-
Maastricht University Medical CenterNovo Nordisk A/SCompletedType 2 DiabetesNetherlands
-
Karolinska InstitutetCompletedType 2 Diabetes MellitusSweden
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
SanofiCompletedType 2 Diabetes MellitusChina, India, Korea, Republic of, Russian Federation
-
CymaBay Therapeutics, Inc.TerminatedType 2 Diabetes MellitusUnited States, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusNetherlands, Canada
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Spain, Canada
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Taiwan, India
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Poland, Hungary, Mexico, Greece, Australia
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
University Hospitals, LeicesterDepartment of Health, United KingdomUnknownType 2 Diabetes MellitusUnited Kingdom
-
SanofiCompletedType 2 Diabetes MellitusSouth Africa, United States, Mexico, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Tel Aviv UniversityCompletedType 2 Diabetes MellitusIsrael